Chemical Structure (Motegrity 01)
Motegrity Tablet, Film Coated
Product Images NDC 54092-547
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Motegrity (NDC 54092-547). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Takeda Pharmaceuticals America, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Principal Display Panel (1 mg Tablet Bottle Label)
This is a description for a medication called "Motegrity". The medication comes in a tablet form and each tablet contains a certain amount of active ingredient. The tablets should be stored at a controlled room temperature, between 20°C and 25°C, and should be kept out of reach of children in their original container. The recommended dose is one tablet per day. The text also includes information about the manufacturer, such as their trademarked logos.*
Principal Display Panel (2 mg Tablet Bottle Carton)
Mategrity® is a medication in the form of tablets which contain prucalopride (2mg) and are stored at a temperature between 20-25°C. The tablets should be kept in their original container to protect them from moisture, and kept out of reach of children. This medication is distributed by Takeda Pharmaceuticals in America, and the recommended dose is one tablet per day. This text is related to instructions for storing and administering Mategrity® tablets.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
